Unknown

Dataset Information

0

A novel small compound that promotes nuclear translocation of YB-1 ameliorates experimental hepatic fibrosis in mice.


ABSTRACT: Transforming growth factor-? (TGF-?) is considered to be a major factor contributing to liver fibrosis. We have previously shown that nuclear translocation of YB-1 antagonizes the TGF-?/Smad3 signaling in regulating collagen gene expression. More recently, we have demonstrated that the novel small compound HSc025 promotes nuclear translocation of YB-1, resulting in the improvement of skin and pulmonary fibrosis. Here, we presented evidence as to the mechanism by which HSc025 stimulates nuclear translocation of YB-1 and the pharmacological effects of HSc025 on a murine model of hepatic fibrosis. A proteomics approach and binding assays using HSc025-immobilized resin showed that HSc025 binds to the amino acid sequence within the C-tail region of YB-1. In addition, immunoprecipitation experiments and glutathione S-transferase pulldown assays identified poly(A)-binding protein (PABP) as one of the cytoplasmic anchor proteins of YB-1. HSc025 directly binds to YB-1 and interrupts its interaction with PABP, resulting in accelerated nuclear translocation of YB-1. Transfection of cells with PABP siRNA promoted nuclear translocation of YB-1 and subsequently inhibited basal and TGF-?-stimulated collagen gene expression. Moreover, HSc025 significantly suppressed collagen gene expression in cultured activated hepatic stellate cells. Oral administration of HSc025 to mice with carbon tetrachloride-induced hepatic fibrosis improved liver injury as well as the degree of hepatic fibrosis. Altogether, the results provide a novel insight into therapy for organ fibrosis using YB-1 modulators.

SUBMITTER: Higashi K 

PROVIDER: S-EPMC3039351 | biostudies-literature | 2011 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

A novel small compound that promotes nuclear translocation of YB-1 ameliorates experimental hepatic fibrosis in mice.

Higashi Kiyoshi K   Tomigahara Yoshitaka Y   Shiraki Hiroaki H   Miyata Kaori K   Mikami Toshiyuki T   Kimura Toru T   Moro Tadashi T   Inagaki Yutaka Y   Kaneko Hideo H  

The Journal of biological chemistry 20101128 6


Transforming growth factor-β (TGF-β) is considered to be a major factor contributing to liver fibrosis. We have previously shown that nuclear translocation of YB-1 antagonizes the TGF-β/Smad3 signaling in regulating collagen gene expression. More recently, we have demonstrated that the novel small compound HSc025 promotes nuclear translocation of YB-1, resulting in the improvement of skin and pulmonary fibrosis. Here, we presented evidence as to the mechanism by which HSc025 stimulates nuclear t  ...[more]

Similar Datasets

| S-EPMC5855969 | biostudies-literature
| S-EPMC3792002 | biostudies-literature
| S-EPMC8745666 | biostudies-literature
| S-EPMC6904731 | biostudies-literature
| S-EPMC3520929 | biostudies-literature
| S-EPMC5325423 | biostudies-literature
| S-EPMC7581713 | biostudies-literature
| S-EPMC1794381 | biostudies-literature
| S-EPMC5341405 | biostudies-literature
| S-EPMC2705470 | biostudies-literature